MeSH D004942 - peptic esophagitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ranitidine | Ranitidine |  | 2003-10-31 |  |  |
| Taro Pharmaceutical | Ranitidine | Ranitidine |  | 2011-06-13 |  |  |
| Glenmark Pharmaceuticals | Ranitidine | Ranitidine |  | 2008-11-19 |  |  |
| Mylan | Ranitidine | Ranitidine |  | 1997-08-22 |  |  |
| Dexlansoprazole | Dexlansoprazole |  | 2024-01-19 |  |  | |
| Perrigo | Ranitidine | Ranitidine |  | 2002-08-30 |  |  |
| GSK | Ranitidine | Zantac |  | 1983-06-09 |  |  |
| Ranitidine | Tritec |  | 1996-08-08 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
86%6/7
Phase 3
85%11/13
Approved: 6Overall Success rate: 36%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use